Trial Profile

Phase II study of oxaliplatin based regimen in relapsed colon cancer patients treated with oxaliplatin based adjuvant

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 25 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oxaliplatin (Primary) ; Bevacizumab; Capecitabine; Cetuximab; Fluoropyrimidine derivatives; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur; Panitumumab
Indications Colon cancer; Colorectal cancer
Focus Therapeutic Use
Acronyms INSPIRE

Most Recent Events

21 Sep 2020 Results assessing update analysis on efficacy and allergic reactions due to Ox re-introduction presented at the 45th European Society for Medical Oncology Congress
04 Jul 2020 Results presented at the 22nd World Congress on Gastrointestinal Cancer
06 Aug 2019 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com